ARCHIVES

ODACSupports Temodal For Treatment of Astrocytoma

This article is from The Cancer Letter archive.

Vol. 25 No. 03 | January 22, 1999

Download PDF Visit The Full Archive

Related Articles

Avastin Increases Overall Survival 3.7 Months

February 22, 2013

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Barakat Named Deputy Physician-in-Chief Of Memorial Sloan-Kettering’s Regional Care Network

October 18, 2013

Hutchinson Center Receives NCI Grant For Immunotherapy Network

October 15, 2010

Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts

November 23, 1974